Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
Mònica Ortega Llobet(Karolinska Institutet), Matti Lehtinen(Karolinska Institutet), Joakim Dillner(Karolinska University Hospital), Tiina Eriksson(Tampere University), Penelope Gray(Karolinska University Hospital), Ville N. Pimenoff(Karolinska Institutet), Camilla Lagheden(Karolinska Institutet), Iacopo Baussano(Centre International de Recherche sur le Cancer), Miriam Elfström(Karolinska University Hospital), Pekka Nieminen(University of Helsinki), Anna Söderlund‐Strand(Canadian Institutes of Health Research)
Cited by 5
Related Papers
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
Tuberculosis Incidence in Prisons: A Systematic Review
|PLoS Medicine|2010|350